Lisa Yen (@lisayentwin) 's Twitter Profile
Lisa Yen

@lisayentwin

Director of Programs/Outreach, Neuroendocrine Cancer Foundation @NCFCancer (formerly @LACNETS); NP Hospitalist turned NET caregiver+pt advocate. Tweets mine

ID: 585437487

linkhttps://www.ncf.net/ calendar_today20-05-2012 04:27:35

1,1K Tweet

720 Followers

595 Following

Julie Hallet (@halletjulie) 's Twitter Profile Photo

What to do with carcinoid crisis? 🦓 A frequent concern for patients with #NETs having surgery We put together an international🌎🌍🌏 multidisciplinary expert consensus statement 📢 Now open for feedback! Sign-up here 🔗 surveymonkey.com/r/periopcarcin… 📆Open until March 3rd!

What to do with carcinoid crisis? 🦓 A frequent concern for patients with #NETs having surgery 

We put together an international🌎🌍🌏 multidisciplinary expert consensus statement
📢 Now open for  feedback!
 
Sign-up here 🔗 surveymonkey.com/r/periopcarcin…

📆Open until March 3rd!
Neuroendocrine Cancer Foundation (@ncfcancer) 's Twitter Profile Photo

#enets2025 - Jaume Capdevila presents the much anticipated results of ITM’s COMPETE study, the first prospective, randomized phase 3 study comparing PRRT with an active treatment (everolimus). Positive results & good tolerability suggest potential for 1L or 2L treatment GEPNETS

#enets2025 - <a href="/Ja_Capdevila/">Jaume Capdevila</a> presents the much anticipated results of ITM’s COMPETE study, the first prospective, randomized phase 3 study comparing PRRT with an active treatment (everolimus). Positive results &amp; good tolerability suggest potential for 1L or 2L treatment GEPNETS
Neuroendocrine Cancer Foundation (@ncfcancer) 's Twitter Profile Photo

#enets2025 ENETS-INCA joint session Thor Halfdanarson on Meaningful involvement of pts in NEN research Meredith Cummins NeuroEndocrine Cancer Australia on pts partnering 🌎 Timon Vandamme on aligning researcher & pt priorities Simron Singh on improving global research 🔑Essential to partner w advocates

#enets2025 ENETS-INCA joint session
<a href="/OncoThor/">Thor Halfdanarson</a> on Meaningful involvement of pts in NEN research 

Meredith Cummins <a href="/NECancerAus/">NeuroEndocrine Cancer Australia</a> on pts partnering 🌎  

<a href="/TimonV/">Timon Vandamme</a> on aligning researcher &amp; pt priorities 

Simron Singh on improving global research

🔑Essential to partner w advocates
Neuroendocrine Cancer Foundation (@ncfcancer) 's Twitter Profile Photo

#ENETS2025 - Attention industry & researchers considering global trials: consider opening sites in Latin America to increase diversity and improve access to treatments. Please meet Dra Monica Meneses Mónica Meneses from @INCMNSZ in Mexico City ENETS NANETS CarcinoidCancer CCF

#ENETS2025 - Attention industry &amp; researchers considering global trials: consider opening sites in Latin America to increase diversity and improve access to treatments. 
Please meet Dra Monica Meneses <a href="/MoniquMeneses/">Mónica Meneses</a> from @INCMNSZ in Mexico City <a href="/ENETS_ORG/">ENETS</a> 
<a href="/NANETS1/">NANETS</a> <a href="/CarcinoidNETs/">CarcinoidCancer CCF</a>
Lisa Yen (@lisayentwin) 's Twitter Profile Photo

Thanks Junaid Arshad for hosting amazing NANETS and Neuroendocrine Cancer Foundation educational conferences! Appreciate all your thoughtfulness, hard work and dedication. It was such a pleasure collaborating with you & getting to know you. Let’s keep fighting this fight together!

Thanks <a href="/drjunaidarsh/">Junaid Arshad</a> for hosting amazing <a href="/NANETS1/">NANETS</a> and <a href="/NCFCancer/">Neuroendocrine Cancer Foundation</a> educational conferences! Appreciate all your thoughtfulness, hard work and dedication. It was such a pleasure collaborating with you &amp; getting to know you. Let’s keep fighting this fight together!
Neuroendocrine Cancer Foundation (@ncfcancer) 's Twitter Profile Photo

It is with deep sadness that we share the passing of Dr. Richard R.P. Warner, who left us on June 15, 2025 in Denver, Colorado at the age of 97. A visionary physician and researcher, Dr. Warner founded the Carcinoid Cancer Foundation in 1968. His tireless work has touched

It is with deep sadness that we share the passing of Dr. Richard R.P. Warner, who left us on June 15, 2025 in Denver, Colorado at the age of 97. A visionary physician and researcher, Dr. Warner founded the Carcinoid Cancer Foundation in 1968. His tireless work has touched
Udhayvir Grewal (@ugrewalmd) 's Twitter Profile Photo

So happy to see NETs/NENs as an abstract submission category for next year's @asco GI symposium (#GI26). With the rising incidence of NETs and rapid advances in diagnosis and treatment, it is so important that we encourage more research and collaborative efforts to help improve

So happy to see NETs/NENs as an abstract submission category for next year's @asco GI symposium (#GI26). With the rising incidence of NETs and rapid advances in diagnosis and treatment, it is so important that we encourage more research and collaborative efforts to help improve
Lisa Yen (@lisayentwin) 's Twitter Profile Photo

This is a must watch webinar! Super⭐️ Udhayvir Grewal will explain the rapidly evolving PRRT/RLT landscape in a patient-friendly way. Monday Sept 22nd at 3:30pm PT/6:30pm ET. Register here: ncf.net/events/sep2025

Neuroendocrine Cancer Foundation (@ncfcancer) 's Twitter Profile Photo

New Research Update: Promising Results for Alpha Therapy in NETs October 8, 2025 — Sanofi announced that its investigational treatment AlphaMedix™ (²¹²Pb-DOTAMTATE) met all primary goals in a phase 2 clinical trial, showing meaningful benefits for patients with